[{"id":"37e6eb89-6b57-42a6-a515-a983cfbeb28c","acronym":"MK-7110-002","url":"https://clinicaltrials.gov/study/NCT02663622","created_at":"2021-01-18T12:58:52.613Z","updated_at":"2024-07-02T16:35:22.556Z","phase":"Phase 2","brief_title":"Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)","source_id_and_acronym":"NCT02663622 - MK-7110-002","lead_sponsor":"Oncoimmune, Inc., a subsidiary of Merck \u0026 Co., Inc. (Rahway, New Jersey USA)","biomarkers":" HLA-DRB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e methotrexate • Saccovid (efprezimod alfa)"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 09/19/2016","start_date":" 09/19/2016","primary_txt":" Primary completion: 06/08/2020","primary_completion_date":" 06/08/2020","study_txt":" Completion: 05/18/2021","study_completion_date":" 05/18/2021","last_update_posted":"2024-01-23"},{"id":"7b1f29d9-a661-4502-922c-7d02d9bee371","acronym":"CATHY","url":"https://clinicaltrials.gov/study/NCT04976699","created_at":"2021-07-26T17:53:24.725Z","updated_at":"2024-07-02T16:36:27.451Z","phase":"Phase 3","brief_title":"CD24Fc for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)","source_id_and_acronym":"NCT04976699 - CATHY","lead_sponsor":"Merck Sharp \u0026 Dohme Corp.","biomarkers":" HLA-DRB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e methotrexate • Saccovid (efprezimod alfa)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 11","initiation":"Initiation: 01/05/2021","start_date":" 01/05/2021","primary_txt":" Primary completion: 11/02/2021","primary_completion_date":" 11/02/2021","study_txt":" Completion: 11/02/2021","study_completion_date":" 11/02/2021","last_update_posted":"2021-07-26"}]